Thoracoabdominal Aortic Aneurysms
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Fenestrated and branched endovascular devices for TAAA.
- Who it may be relevant to
- Registry conditions: Thoracoabdominal Aortic Aneurysm. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Outcomes of Endovascular Repair of Thoracoabdominal Aortic Aneurysms
Overview
Evaluation of the effectiveness of the different modalities for treatment of thoracoabdominal aortic aneurysms. FEVAR and BEVAR devices are widely used now due to its feasability and wide range of use . We aim to evaluate the effectiveness of these new devices in the management of TAAA
Interventions
- Device Fenestrated and branched endovascular devices for TAAA
Devices for TAAA
Primary outcome measures
- Successful cannulation of the target vessels with complete in-line flow to target organs. [Time frame: Two years]
Eligibility criteria
Inclusion criteria
- all adult consecutive patients presenting with TAAA larger than 5.5 cm
Exclusion criteria
- active infection Asymptomatic patients with small aneurysms Allergy to contrast agents
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06267573 · Kerolos protocol